Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Spontaneous Intracerebral Hemorrhage
NCT07088250Recruiting
- Sponsor
- The Second Affiliated Hospital of Anhui Medical University
- Start
- May 2023
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of atorvastatin in intracerebral hemorrhage (ICH) (2 arms), sponsored by The Second Affiliated Hospital of Anhui Medical University. Primary endpoint: Proportion of patients with a poor functional outcome (mRS 4-6) at 90 days. Started May 2023; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT07088250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07088250.